Close Menu

In this week's PNAS Early Edition, Eugene Gladyshev and Irina Arkhipova at the Marine Biological Laboratory in Woods Hole, Mass., present evidence that suggests the class of class of reverse transcriptase-related cellular genes collectively called rvts "are not components of retrotransposons or viruses, but [are] single-copy genes with a characteristic domain structure that may contain introns in evolutionarily conserved positions, occur in syntenic regions, and evolve under purifying selection." Gladyshev and Arkhipova show that these genes "can be found in all major taxonomic gro

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.